Neural Therapeutics Inc. is an ethnobotanical drug discovery/development company focused on developing products and conducting research with psychoactive plants, the first being a cactus commonly known as San Pedro (Echinopsis pachanoi) containing mescaline. Neural Therapeutics aims to identify where plant-based traditional-medicine has proven to be effective and capitalize on two development paths.One that includes Mescaline (Pharmaceutical) and the other where Mescaline is absent (Nutraceutical)